What happened to my Cystatin C test results to confirm my impaired eGFR?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Likely Happened to Your Cystatin C Test Results

Your cystatin C test is likely delayed because many laboratories in the United States do not routinely perform this assay on-site and must send specimens to reference laboratories, which can take several days to over a week for results to return. 1

Why Cystatin C Testing Takes Longer

Laboratory Availability Issues

  • Cystatin C assays are not widely available in many countries, including the U.S. and Canada, despite being recommended by guidelines 2, 3
  • Most clinical laboratories must send cystatin C samples to specialized reference laboratories rather than performing the test in-house 1
  • This send-out process typically adds 3-7 days (or more) to turnaround time compared to routine creatinine testing

Technical Requirements

  • Cystatin C requires specific assay calibration traceable to international standard reference materials, which not all laboratories maintain 2
  • The test requires specialized equipment and trained personnel that many routine clinical laboratories lack 4

Why Your Doctor Ordered This Test

With your eGFR of 58 mL/min/1.73 m², you fall into the exact category where KDIGO guidelines suggest measuring cystatin C to confirm whether you truly have chronic kidney disease. 1

The Clinical Rationale

  • Guidelines recommend cystatin C for adults with creatinine-based eGFR of 45-59 mL/min/1.73 m² who lack other markers of kidney damage (such as proteinuria) 1, 2
  • If your cystatin C-based eGFR comes back ≥60 mL/min/1.73 m², the diagnosis of CKD would not be confirmed 1, 2
  • If your cystatin C-based eGFR is also <60 mL/min/1.73 m², then CKD diagnosis is confirmed 1, 2

Important Context About This Testing Strategy

  • Research shows that approximately 23% of patients with creatinine-based eGFR in your range (45-59) actually have normal kidney function when confirmed with cystatin C 2
  • However, 65% of patients tested have a cystatin C-based eGFR that is lower than their creatinine-based eGFR, meaning more people are reclassified to worse kidney function than better 5

What to Expect When Results Arrive

Interpretation Framework

  • Your results will include an eGFR calculated from cystatin C alone (eGFRcys) and likely a combined creatinine-cystatin C equation (eGFRcreat-cys) 1
  • The combined equation (eGFRcreat-cys) provides the most accurate GFR estimation and should guide clinical decisions 1, 2

Potential Outcomes

  • If eGFRcys ≥60: Your declining creatinine-based eGFR may reflect factors other than true kidney disease (such as muscle mass changes, diet, or medications) rather than actual kidney damage 1, 2
  • If eGFRcys <60: This confirms reduced kidney function and warrants appropriate CKD management and monitoring 1, 2

Common Pitfalls to Avoid

  • Do not assume the delay means something is wrong with your kidneys—the delay is purely logistical due to laboratory processing 1
  • Be aware that cystatin C can be affected by thyroid dysfunction, smoking, and high-dose corticosteroids, which should be considered when interpreting results 2, 6
  • If you have significant muscle mass changes, malnutrition, or chronic inflammatory conditions, both creatinine and cystatin C may have limitations 2, 6

Cost Considerations

  • Cystatin C testing costs more than routine creatinine testing, though the "triple marker" panel (creatinine, cystatin C, and urine albumin) is considered affordable in high-income settings 2
  • The higher cost is one reason why cystatin C has not been widely adopted despite guideline recommendations 2, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Role of Serum Cystatin C in Assessing Kidney Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cystatin C--a paradigm of evidence based laboratory medicine.

The Clinical biochemist. Reviews, 2008

Research

Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2023

Research

Estimated GFR: time for a critical appraisal.

Nature reviews. Nephrology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.